Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings.
about
Insulin and insulin resistance.Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugsHigh Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ FunctionsA prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes.Cardiovascular impact of drugs used in the treatment of diabetesSubmandibular gland and caries susceptibility in the obese Zucker rat.Diabesity: an inflammatory metabolic condition.How does blood glucose control with insulin save lives in intensive care?Sarcopenic obesity and cognitive functioning: the mediating roles of insulin resistance and inflammation?Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease.Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1β via p38 mitogen-activated protein kinase.The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients.Prevailing vitamin D status influences mitochondrial and glycolytic bioenergetics in peripheral blood mononuclear cells obtained from adults.Assessment of C-reactive Protein and C3 as Inflammatory Markers of Insulin Resistance in Women with Polycystic Ovary Syndrome: A Case-Control StudyThe Role of Immunogenicity in Cardiovascular Disease.Complement C3 as a marker of cardiometabolic risk in psoriasis.Insulin resistance in early vs late nutrition and complications of sirs in neurosurgical intensive care unit (ICU).Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathwayDiet-induced obesity and kidney disease - In search of a susceptible mouse model.Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity.Depressive symptoms in older people with metabolic syndrome: is there a relationship with inflammation?Effect of family history of type 2 diabetes on white blood cell count in adult women.Effect of long-term Helicobacter felis infection in a mouse model of streptozotocin-induced diabetes.A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice.Metabolic syndrome and inflammation in adipose tissue occur at different times in animals submitted to a high-sugar/fat diet.Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.Inflammation markers predict increased weight gain in smoking quitters.Lipopolysaccharide Potentiates Insulin-Driven Hypoglycemic Shock.Medical history and the risk of biliary tract cancers in Shanghai, China: implications for a role of inflammation.Effects of short-term supplementation with bovine lactoferrin and/or immunoglobulins on body mass and metabolic measures: a randomised controlled trial.Pyrrolidine Dithiocarbamate Inhibits Interleukin-6 Signaling through Impaired STAT3 Activation and Association with Transcriptional Coactivators in Hepatocytes
P2860
Q24532776-5ECFCDB3-9DA3-4DD0-8AE3-893A3E5EB934Q28246959-A8E605AF-3039-40EA-B9E6-25C926F9D8BFQ33616618-8EB8DA2B-A12B-4BB9-9826-5590DD1035F4Q34153214-B4F0C608-D68E-4217-9A45-B4620A5E37BEQ34383575-D8D62CD2-970B-48C9-935C-5C534DBF598AQ34538250-81CD7C88-80C6-4ABF-8D33-B4A41461161DQ35576062-5C710170-F51A-4926-AC12-5AE7D71843B1Q35936472-B4000E5A-7327-472C-8DBB-345449C73B2EQ35960158-7EE52417-DB74-4380-A89A-E10581579CFDQ36263853-028CC287-2376-486C-A8BB-7508BDD65E79Q36943048-73A47344-7B8A-4EE5-A028-B9E7BBB1C432Q37391517-92A656AA-ABD1-4D19-81E4-F3FCF113DB61Q37396951-8C37ED12-7E7A-464E-8732-3A9058415842Q37548007-AB65936C-D8CB-499D-B0AB-D308F2D6433BQ37560012-A03865FE-09A6-4AFB-A638-CE927786D9F5Q39188717-6C6FE2DA-9CBC-4615-88A9-08674DEC2C34Q39210633-6218B443-1D4A-4D0C-80D2-80C1E56272AEQ41027551-E2586D84-475C-4ED3-A300-09404A8799A6Q42062261-744A3325-02C5-4A6A-9C76-945E64E27921Q42703006-6DF5F8AA-C019-4BE3-9D2A-5099E4D02C5EQ44612344-11CAB427-D084-4E4A-9D5F-5B40E4E6935BQ44625320-7E445CC6-C7B3-442B-A630-622067D60858Q46816065-1282C0BA-9035-4A1E-8EAD-A09F1191C4D5Q46858371-058A908A-20F8-4EE7-AB34-56F78BB3A519Q47137902-048ABB94-9399-43A3-88C7-81DA53C1E85CQ47261536-3D650DE5-8678-437A-BD00-988E75CCBD06Q47436687-BA916C79-E637-4BD2-96AF-1A60400946EFQ47643834-F332340D-1645-4731-9185-F2B2EEB39878Q50177231-1F63D9CC-E396-4E83-8407-84476D556044Q51534512-0C15B6BC-BC4E-4547-B4CA-BD4A0178677CQ57372526-CE917829-56B3-4E71-B6CB-3F21AE21C72A
P2860
Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mediators of cytokine-induced ...... d other inflammatory settings.
@ast
Mediators of cytokine-induced ...... d other inflammatory settings.
@en
Mediators of cytokine-induced ...... d other inflammatory settings.
@nl
type
label
Mediators of cytokine-induced ...... d other inflammatory settings.
@ast
Mediators of cytokine-induced ...... d other inflammatory settings.
@en
Mediators of cytokine-induced ...... d other inflammatory settings.
@nl
prefLabel
Mediators of cytokine-induced ...... d other inflammatory settings.
@ast
Mediators of cytokine-induced ...... d other inflammatory settings.
@en
Mediators of cytokine-induced ...... d other inflammatory settings.
@nl
P1476
Mediators of cytokine-induced ...... d other inflammatory settings.
@en
P2093
André Marette
P304
P356
10.1097/00075197-200207000-00005
P577
2002-07-01T00:00:00Z